Your browser doesn't support javascript.
loading
Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR.
van Stekelenborg, John; Ellenius, Johan; Maskell, Simon; Bergvall, Tomas; Caster, Ola; Dasgupta, Nabarun; Dietrich, Juergen; Gama, Sara; Lewis, David; Newbould, Victoria; Brosch, Sabine; Pierce, Carrie E; Powell, Gregory; Ptaszynska-Neophytou, Alicia; Wisniewski, Antoni F Z; Tregunno, Phil; Norén, G Niklas; Pirmohamed, Munir.
Affiliation
  • van Stekelenborg J; Janssen R&D, Horsham, PA, USA. JVanstek@its.jnj.com.
  • Ellenius J; Uppsala Monitoring Centre, Uppsala, Sweden.
  • Maskell S; Department of Electrical Engineering and Electronics, University of Liverpool, Liverpool, L69 3GJ, UK.
  • Bergvall T; Department of Computer Science, University of Liverpool, Liverpool, L69 3BX, UK.
  • Caster O; Uppsala Monitoring Centre, Uppsala, Sweden.
  • Dasgupta N; Uppsala Monitoring Centre, Uppsala, Sweden.
  • Dietrich J; Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.
  • Gama S; Pharmacovigilance, Bayer AG, Berlin, Germany.
  • Lewis D; Chief Medical Office and Patient Safety, Novartis Global Drug Development, Novartis Pharma Basel, Basel, Switzerland.
  • Newbould V; Chief Medical Office and Patient Safety, Novartis Global Drug Development, Novartis Pharma Basel, Basel, Switzerland.
  • Brosch S; Dept of Pharmacy, Pharmacology and Postgraduate Medicine, University of Hertfordshire, Hatfield, UK.
  • Pierce CE; Pharmacovigilance Department, Inspections and Human Medicines Pharmacovigilance Division, European Medicines Agency (EMA), Amsterdam, The Netherlands.
  • Powell G; Pharmacovigilance Department, Inspections and Human Medicines Pharmacovigilance Division, European Medicines Agency (EMA), Amsterdam, The Netherlands.
  • Ptaszynska-Neophytou A; Booz Allen Hamilton (formerly Epidemico, Inc.), Boston, MA, USA.
  • Wisniewski AFZ; GlaxoSmithKline, Global Clinical Safety and Pharmacovigilance, RTP, Research Triangle Park, NC, 27709, USA.
  • Tregunno P; Vigilance, Intelligence and Research Group, Medicines and Healthcare products Regulatory Agency (MHRA), 10 South Colonnade, Canary Wharf, London, E14 4PU, UK.
  • Norén GN; AstraZeneca, Patient Safety, Office of the Chief Medical Officer, Cambridge, UK, Granta Park, Cambridge, CB21 6GH, UK.
  • Pirmohamed M; Vigilance, Intelligence and Research Group, Medicines and Healthcare products Regulatory Agency (MHRA), 10 South Colonnade, Canary Wharf, London, E14 4PU, UK.
Drug Saf ; 42(12): 1393-1407, 2019 12.
Article in En | MEDLINE | ID: mdl-31446567
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacovigilance / Social Media Type of study: Guideline Limits: Humans Language: En Journal: Drug Saf Journal subject: TERAPIA POR MEDICAMENTOS / TOXICOLOGIA Year: 2019 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacovigilance / Social Media Type of study: Guideline Limits: Humans Language: En Journal: Drug Saf Journal subject: TERAPIA POR MEDICAMENTOS / TOXICOLOGIA Year: 2019 Document type: Article Affiliation country: Country of publication: